title: Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.
abstract: With the current enzootic circulation of highly pathogenic avian influenza viruses, the ability to increase global pandemic influenza vaccine production capacity is of paramount importance. This has been highlighted by, and is one of the main pillars of, the WHO Global Action Plan for Influenza Vaccines (GAP). Such capacity expansion is especially relevant in developing countries. The Vaccine Formulation Laboratory at University of Lausanne is engaged in the technology transfer of an antigen-sparing oil-in-water adjuvant in order to empower developing countries vaccine manufacturers to increase pandemic influenza vaccine capacity. In a one-year project funded by United States Department of Health and Human Services, the Vaccine Formulation Laboratory transferred the process know-how and associated equipment for the pilot-scale manufacturing of an oil-in-water adjuvant to Bio Farma, Indonesia's state-owned vaccine manufacturer, for subsequent formulation with H5N1 pandemic influenza vaccines. This paper describes the experience acquired and lessons learnt from this technology transfer project.
authors.affiliation: Vaccine Formulation Laboratory, Department of Biochemistry, University of Lausanne, Chemin des Boveresses 155, Epalinges CH-1066, Switzerland.
authors.forename: Roland
authors.initials: R
authors.lastname: Ventura
authors.forename: Livia
authors.initials: L
authors.lastname: Brunner
authors.forename: Bambang
authors.initials: B
authors.lastname: Heriyanto
authors.forename: Otto
authors.initials: O
authors.lastname: de Boer
authors.forename: Michael
authors.initials: M
authors.lastname: O'Hara
authors.forename: Chuong
authors.initials: C
authors.lastname: Huynh
authors.forename: Mahendra
authors.initials: M
authors.lastname: Suhardono
authors.forename: Nicolas
authors.initials: N
authors.lastname: Collin
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000592:standards*; D003906:Developing Countries; D005161:Facility Regulation and Control; D007214:Indonesia; D007252:Influenza Vaccines / Q000494:pharmacology / Q000592:standards*; D007391:International Cooperation; D011786:Quality Control; D013185:Squalene / Q000494:pharmacology; D018581:Technology Transfer; D013678:Technology, Pharmaceutical / Q000379:methods / Q000592:standards*
chemical_list: D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; D013185:Squalene